home / openregs

documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

20 rows where docket_id = "FDA-2019-P-6045" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), last_modified (date)

posted_year 3

  • 2019 15
  • 2020 4
  • 2022 1

document_type 2

  • Supporting & Related Material 16
  • Other 4

agency_id 1

  • FDA 20
id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2019-P-6045-0021 FDA None FDA-2019-P-6045 Final Response Letter from FDA CFSAN to Hyman Phelps and McNamara PC Other Response(s) 2022-04-27T04:00:00Z 2022 4 2022-04-27T04:00:00Z   2022-04-27T14:10:06Z   0 0 0900006485039ba1
FDA-2019-P-6045-0019 FDA None FDA-2019-P-6045 180-day Interim Response to the Wacker Chemical Corporation Other Letter(s) 2020-06-12T04:00:00Z 2020 6 2020-06-12T04:00:00Z   2022-01-27T02:00:27Z   0 0 09000064846ea0f7
FDA-2019-P-6045-0017 FDA None FDA-2019-P-6045 Appendix A and B from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2020-02-03T05:00:00Z 2020 2     2020-02-03T16:07:56Z   0 0 0900006484321903
FDA-2019-P-6045-0016 FDA None FDA-2019-P-6045 Cover letter from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2020-02-03T05:00:00Z 2020 2     2020-02-03T16:08:11Z   0 0 0900006484321902
FDA-2019-P-6045-0018 FDA None FDA-2019-P-6045 Alpha-Cyclodextrin Attenuates the Glycemic and Insulinemic Impact of White Bread in Healthy Male Volunteers from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2020-02-03T05:00:00Z 2020 2     2020-02-03T16:07:44Z   0 0 0900006484321904
FDA-2019-P-6045-0010 FDA None FDA-2019-P-6045 Attachment 8 Koukiekolo R., et al (2001) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:49:42Z   0 0 0900006484251ef0
FDA-2019-P-6045-0002 FDA None FDA-2019-P-6045 Acknowledgment Letter from FDA DMS to Hyman, Phelps and McNamara, P.C. Other Acknowledgement Letter/Receipt 2019-12-27T05:00:00Z 2019 12 2019-12-27T05:00:00Z   2019-12-27T17:20:01Z   0 0 09000064842518e7
FDA-2019-P-6045-0004 FDA None FDA-2019-P-6045 Attachment 2 Diamantis I., et al (2019). re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:47:38Z   0 0 0900006484251ab1
FDA-2019-P-6045-0007 FDA None FDA-2019-P-6045 Attachment 5 Gentilcore D., et al (2011) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:48:44Z   0 0 0900006484251b7e
FDA-2019-P-6045-0015 FDA None FDA-2019-P-6045 Attachment 13 Van Ommen B., et al (2004) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:51:51Z   0 0 0900006484251ef5
FDA-2019-P-6045-0006 FDA None FDA-2019-P-6045 Attachment 4 Fletcher (2013) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:48:10Z   0 0 0900006484251b7d
FDA-2019-P-6045-0011 FDA None FDA-2019-P-6045 Attachment 9 Lightowler H., et al (2018) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:50:08Z   0 0 0900006484251ef1
FDA-2019-P-6045-0005 FDA None FDA-2019-P-6045 Attachment 3 EFSA (2012) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:47:54Z   0 0 0900006484251b7c
FDA-2019-P-6045-0012 FDA None FDA-2019-P-6045 Attachment 10 McCleary B.V., et al (2004) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:50:33Z   0 0 0900006484251ef2
FDA-2019-P-6045-0008 FDA None FDA-2019-P-6045 Attachment 6 Jarosz P.A., et al (2013) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:48:58Z   0 0 0900006484251b7f
FDA-2019-P-6045-0009 FDA None FDA-2019-P-6045 Attachment 7 Kondo, H., et al (1990) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:49:25Z   0 0 0900006484251eef
FDA-2019-P-6045-0003 FDA None FDA-2019-P-6045 Attachment 1 Buckley J.D., et al (2006) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:47:18Z   0 0 09000064842518ec
FDA-2019-P-6045-0013 FDA None FDA-2019-P-6045 Attachment 11 Oudjeriouat N.,et al (2003) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:51:18Z   0 0 0900006484251ef3
FDA-2019-P-6045-0001 FDA None FDA-2019-P-6045 Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Other Citizen Petition 2019-12-27T05:00:00Z 2019 12 2019-12-27T05:00:00Z   2022-04-27T14:03:34Z   0 0 0900006484250c64
FDA-2019-P-6045-0014 FDA None FDA-2019-P-6045 Attachment 12 Sugahara M., et al (2016) re Citizen Petition from Hyman, Phelps and McNamara, P.C. on behalf of Wacker Chemical Corporation Supporting & Related Material Background Material 2019-12-27T05:00:00Z 2019 12     2019-12-27T17:51:35Z   0 0 0900006484251ef4

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options:

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;
Powered by Datasette · Queries took 29.176ms · Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API